Tagged with DIA

India Raghuveer Kini, executive director of the Pharmaceuticals Export Promotion Council of India (Pharmexcil) provides insights into the key success factors that have allowed India to become the world’s pharmaceutical hub and gives us his assessment of the recent plateauing of Indian exports as well as an overview of the new…

India Jean-Pierre Baylet, country head for India and cluster head for South Asia at Sanofi Pasteur, provides insights into the progress and room for improvement that lie ahead for India’s immunization program, while highlighting Sanofi’s unrivalled commitment to protecting the Indian population from vaccine- preventable diseases like polio and flu as…

India Dr. Deepak Sawant, Minister of Public Health and Family Welfare in the Government of Maharashtra, provides insights into some crucial achievements with regards to the state’s infant and child mortality rates, the improvement of Maharashtra’s emergency response and ambulance system, and the prevention of oral cancer. While highlighting the state’s…

India The global pharmaceutical outsourcing market was estimated to be USD 115.7 billion in 2016, of which 49 percent is accounted for by contract research organisations (CROs). Within India, the contract research market is scheduled to grow from around USD one billion in 2016 to USD 1.97 billion by 2023 according…

India In this exclusive interview, Binish Chudgar, vice-chairman and managing director of Intas, the largest privately-owned Indian pharmaceutical company with sales of over USD 1.7 billion during the last financial year, provides insights into the company’s growth model and M&A approach, as well as his objectives with regards to a large-scale…

India Vishal Thakker and Sunny Bhatia, co-founders and managing partners at Antonov Industrial Parks, provides insights into the unique offering of this ambitious and upcoming industrial development company, which offers highly equipped advanced industrial and warehousing solutions to pharmaceutical companies across India’s most strategic hubs. Could you introduce Antonov Industrial Parks…

India Gaurav Aggarwal, Director of Lasons India Pvt Ltd and CEO of ‘OneLife’ the consumer division, highlights the key milestones of almost four decades in business that has helped them become a global exporters of Vitamin B3 (Niacin & Niacinamide). With passion, he also shares how he is committed to bring…

India India’s pharmaceutical sales and forecast from 2013 up to 2021. Between 2017 and 2021, the Indian pharma market is forecasted to grow by a CAGR of between nine and ten percent. The Indian biotechnology market grew by a CAGR of 20.33% between 2005 and 2015 and stood at USD 11.6…

India The top 15 pharma companies in India for 2017 ranked by market share and growth rate. Homegrown champions Sun Pharma, Cipla and Zydus Cadila lead the way with 5.5, 4.6 and 3.9% market shares respectively.

India Satish Varma, managing director of Fermenta Biotech Ltd., one of the world’s largest and leading producers of Vitamin D3, provides insights into the indisputable benefits brought by the “Vitamin of the Century”, his approach to instill the best quality and regulatory standards in the company as well as his priorities…

Canada Despite Canada’s provincial approach to healthcare, Steve Gundersen, president of BD Canada’s operations, praises the collaborative spirit of healthcare stakeholders at all levels in order to overcome the challenges, such as a decentralized system, and to make a meaningful difference to Canadian patients. Having spent most of your career with…

Pharma India leads the way in terms of the sheer volume of US FDA-approved manufacturing plants with over 100, compared to only 28 in China. In terms of the global competitiveness of Brazil, Russia, India, China and South Africa (BRICS), China remained out in front between 2012 and 2015, with India…